Global Cardiovascular Genetic Testing Market Growth (Status and Outlook) 2022-2028
Cardiomyopathies, arrhythmic disorders, thoracic aortic aneurysms and dissections, and familial hypercholesterolemia (FH) are among the inherited cardiovascular diseases for which genetic testing is instructive and beneficial.
The global market for Cardiovascular Genetic Testing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Cardiovascular Genetic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Cardiovascular Genetic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Cardiovascular Genetic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Cardiovascular Genetic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Cardiovascular Genetic Testing players cover Abbott, Bio-Rad Laboratories Inc, Danaher, Daan Gene Co., Ltd and F. Hoffmann-La Roche, Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Cardiovascular Genetic Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Cardiovascular Genetic Testing market, with both quantitative and qualitative data, to help readers understand how the Cardiovascular Genetic Testing market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Cardiovascular Genetic Testing market and forecasts the market size by Type (Cytogenetic Testing, Biochemical Assays and Molecular Testing), by Application (Alzheimer Disease, Sickle Cell Anemia, Cystic Fibrosis and Cancer), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Cytogenetic Testing
Biochemical Assays
Molecular Testing
Segmentation by application
Alzheimer Disease
Sickle Cell Anemia
Cystic Fibrosis
Cancer
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Abbott
Bio-Rad Laboratories Inc
Danaher
Daan Gene Co., Ltd
F. Hoffmann-La Roche, Ltd
Genentech, Inc
Genomictree, Inc
HTG Molecular Diagnostics, Inc
Illumina, Inc
Integragen
Laboratory Corporation of America Holdings
Luminex Corporation
Molecular MD Corp
Myriad Genetics, Inc
Natera, Inc
Oxford Biodynamics Plc
PacBio
PerkinElmer Inc
Qiagen
Thermo Fisher Scientific, Inc
Chapter Introduction
Chapter 1: Scope of Cardiovascular Genetic Testing, Research Methodology, etc.
Chapter 2: Executive Summary, global Cardiovascular Genetic Testing market size and CAGR, Cardiovascular Genetic Testing market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Cardiovascular Genetic Testing revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Cardiovascular Genetic Testing revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Cardiovascular Genetic Testing market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Abbott, Bio-Rad Laboratories Inc, Danaher, Daan Gene Co., Ltd, F. Hoffmann-La Roche, Ltd, Genentech, Inc, Genomictree, Inc, HTG Molecular Diagnostics, Inc and Illumina, Inc, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cardiovascular Genetic Testing Market Size 2017-2028
2.1.2 Cardiovascular Genetic Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Cardiovascular Genetic Testing Segment by Type
2.2.1 Cytogenetic Testing
2.2.2 Biochemical Assays
2.2.3 Molecular Testing
2.3 Cardiovascular Genetic Testing Market Size by Type
2.3.1 Cardiovascular Genetic Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Cardiovascular Genetic Testing Market Size Market Share by Type (2017-2022)
2.4 Cardiovascular Genetic Testing Segment by Application
2.4.1 Alzheimer Disease
2.4.2 Sickle Cell Anemia
2.4.3 Cystic Fibrosis
2.4.4 Cancer
2.4.5 Other
2.5 Cardiovascular Genetic Testing Market Size by Application
2.5.1 Cardiovascular Genetic Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Cardiovascular Genetic Testing Market Size Market Share by Application (2017-2022)
3 Cardiovascular Genetic Testing Market Size by Player
3.1 Cardiovascular Genetic Testing Market Size Market Share by Players
3.1.1 Global Cardiovascular Genetic Testing Revenue by Players (2020-2022)
3.1.2 Global Cardiovascular Genetic Testing Revenue Market Share by Players (2020-2022)
3.2 Global Cardiovascular Genetic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cardiovascular Genetic Testing by Regions
4.1 Cardiovascular Genetic Testing Market Size by Regions (2017-2022)
4.2 Americas Cardiovascular Genetic Testing Market Size Growth (2017-2022)
4.3 APAC Cardiovascular Genetic Testing Market Size Growth (2017-2022)
4.4 Europe Cardiovascular Genetic Testing Market Size Growth (2017-2022)
4.5 Middle East & Africa Cardiovascular Genetic Testing Market Size Growth (2017-2022)
5 Americas
5.1 Americas Cardiovascular Genetic Testing Market Size by Country (2017-2022)
5.2 Americas Cardiovascular Genetic Testing Market Size by Type (2017-2022)
5.3 Americas Cardiovascular Genetic Testing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cardiovascular Genetic Testing Market Size by Region (2017-2022)
6.2 APAC Cardiovascular Genetic Testing Market Size by Type (2017-2022)
6.3 APAC Cardiovascular Genetic Testing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cardiovascular Genetic Testing by Country (2017-2022)
7.2 Europe Cardiovascular Genetic Testing Market Size by Type (2017-2022)
7.3 Europe Cardiovascular Genetic Testing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cardiovascular Genetic Testing by Region (2017-2022)
8.2 Middle East & Africa Cardiovascular Genetic Testing Market Size by Type (2017-2022)
8.3 Middle East & Africa Cardiovascular Genetic Testing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cardiovascular Genetic Testing Market Forecast
10.1 Global Cardiovascular Genetic Testing Forecast by Regions (2023-2028)
10.1.1 Global Cardiovascular Genetic Testing Forecast by Regions (2023-2028)
10.1.2 Americas Cardiovascular Genetic Testing Forecast
10.1.3 APAC Cardiovascular Genetic Testing Forecast
10.1.4 Europe Cardiovascular Genetic Testing Forecast
10.1.5 Middle East & Africa Cardiovascular Genetic Testing Forecast
10.2 Americas Cardiovascular Genetic Testing Forecast by Country (2023-2028)
10.2.1 United States Cardiovascular Genetic Testing Market Forecast
10.2.2 Canada Cardiovascular Genetic Testing Market Forecast
10.2.3 Mexico Cardiovascular Genetic Testing Market Forecast
10.2.4 Brazil Cardiovascular Genetic Testing Market Forecast
10.3 APAC Cardiovascular Genetic Testing Forecast by Region (2023-2028)
10.3.1 China Cardiovascular Genetic Testing Market Forecast
10.3.2 Japan Cardiovascular Genetic Testing Market Forecast
10.3.3 Korea Cardiovascular Genetic Testing Market Forecast
10.3.4 Southeast Asia Cardiovascular Genetic Testing Market Forecast
10.3.5 India Cardiovascular Genetic Testing Market Forecast
10.3.6 Australia Cardiovascular Genetic Testing Market Forecast
10.4 Europe Cardiovascular Genetic Testing Forecast by Country (2023-2028)
10.4.1 Germany Cardiovascular Genetic Testing Market Forecast
10.4.2 France Cardiovascular Genetic Testing Market Forecast
10.4.3 UK Cardiovascular Genetic Testing Market Forecast
10.4.4 Italy Cardiovascular Genetic Testing Market Forecast
10.4.5 Russia Cardiovascular Genetic Testing Market Forecast
10.5 Middle East & Africa Cardiovascular Genetic Testing Forecast by Region (2023-2028)
10.5.1 Egypt Cardiovascular Genetic Testing Market Forecast
10.5.2 South Africa Cardiovascular Genetic Testing Market Forecast
10.5.3 Israel Cardiovascular Genetic Testing Market Forecast
10.5.4 Turkey Cardiovascular Genetic Testing Market Forecast
10.5.5 GCC Countries Cardiovascular Genetic Testing Market Forecast
10.6 Global Cardiovascular Genetic Testing Forecast by Type (2023-2028)
10.7 Global Cardiovascular Genetic Testing Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Cardiovascular Genetic Testing Product Offered
11.1.3 Abbott Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Bio-Rad Laboratories Inc
11.2.1 Bio-Rad Laboratories Inc Company Information
11.2.2 Bio-Rad Laboratories Inc Cardiovascular Genetic Testing Product Offered
11.2.3 Bio-Rad Laboratories Inc Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bio-Rad Laboratories Inc Main Business Overview
11.2.5 Bio-Rad Laboratories Inc Latest Developments
11.3 Danaher
11.3.1 Danaher Company Information
11.3.2 Danaher Cardiovascular Genetic Testing Product Offered
11.3.3 Danaher Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Danaher Main Business Overview
11.3.5 Danaher Latest Developments
11.4 Daan Gene Co., Ltd
11.4.1 Daan Gene Co., Ltd Company Information
11.4.2 Daan Gene Co., Ltd Cardiovascular Genetic Testing Product Offered
11.4.3 Daan Gene Co., Ltd Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Daan Gene Co., Ltd Main Business Overview
11.4.5 Daan Gene Co., Ltd Latest Developments
11.5 F. Hoffmann-La Roche, Ltd
11.5.1 F. Hoffmann-La Roche, Ltd Company Information
11.5.2 F. Hoffmann-La Roche, Ltd Cardiovascular Genetic Testing Product Offered
11.5.3 F. Hoffmann-La Roche, Ltd Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 F. Hoffmann-La Roche, Ltd Main Business Overview
11.5.5 F. Hoffmann-La Roche, Ltd Latest Developments
11.6 Genentech, Inc
11.6.1 Genentech, Inc Company Information
11.6.2 Genentech, Inc Cardiovascular Genetic Testing Product Offered
11.6.3 Genentech, Inc Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Genentech, Inc Main Business Overview
11.6.5 Genentech, Inc Latest Developments
11.7 Genomictree, Inc
11.7.1 Genomictree, Inc Company Information
11.7.2 Genomictree, Inc Cardiovascular Genetic Testing Product Offered
11.7.3 Genomictree, Inc Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Genomictree, Inc Main Business Overview
11.7.5 Genomictree, Inc Latest Developments
11.8 HTG Molecular Diagnostics, Inc
11.8.1 HTG Molecular Diagnostics, Inc Company Information
11.8.2 HTG Molecular Diagnostics, Inc Cardiovascular Genetic Testing Product Offered
11.8.3 HTG Molecular Diagnostics, Inc Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 HTG Molecular Diagnostics, Inc Main Business Overview
11.8.5 HTG Molecular Diagnostics, Inc Latest Developments
11.9 Illumina, Inc
11.9.1 Illumina, Inc Company Information
11.9.2 Illumina, Inc Cardiovascular Genetic Testing Product Offered
11.9.3 Illumina, Inc Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Illumina, Inc Main Business Overview
11.9.5 Illumina, Inc Latest Developments
11.10 Integragen
11.10.1 Integragen Company Information
11.10.2 Integragen Cardiovascular Genetic Testing Product Offered
11.10.3 Integragen Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Integragen Main Business Overview
11.10.5 Integragen Latest Developments
11.11 Laboratory Corporation of America Holdings
11.11.1 Laboratory Corporation of America Holdings Company Information
11.11.2 Laboratory Corporation of America Holdings Cardiovascular Genetic Testing Product Offered
11.11.3 Laboratory Corporation of America Holdings Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Laboratory Corporation of America Holdings Main Business Overview
11.11.5 Laboratory Corporation of America Holdings Latest Developments
11.12 Luminex Corporation
11.12.1 Luminex Corporation Company Information
11.12.2 Luminex Corporation Cardiovascular Genetic Testing Product Offered
11.12.3 Luminex Corporation Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Luminex Corporation Main Business Overview
11.12.5 Luminex Corporation Latest Developments
11.13 Molecular MD Corp
11.13.1 Molecular MD Corp Company Information
11.13.2 Molecular MD Corp Cardiovascular Genetic Testing Product Offered
11.13.3 Molecular MD Corp Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Molecular MD Corp Main Business Overview
11.13.5 Molecular MD Corp Latest Developments
11.14 Myriad Genetics, Inc
11.14.1 Myriad Genetics, Inc Company Information
11.14.2 Myriad Genetics, Inc Cardiovascular Genetic Testing Product Offered
11.14.3 Myriad Genetics, Inc Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Myriad Genetics, Inc Main Business Overview
11.14.5 Myriad Genetics, Inc Latest Developments
11.15 Natera, Inc
11.15.1 Natera, Inc Company Information
11.15.2 Natera, Inc Cardiovascular Genetic Testing Product Offered
11.15.3 Natera, Inc Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Natera, Inc Main Business Overview
11.15.5 Natera, Inc Latest Developments
11.16 Oxford Biodynamics Plc
11.16.1 Oxford Biodynamics Plc Company Information
11.16.2 Oxford Biodynamics Plc Cardiovascular Genetic Testing Product Offered
11.16.3 Oxford Biodynamics Plc Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Oxford Biodynamics Plc Main Business Overview
11.16.5 Oxford Biodynamics Plc Latest Developments
11.17 PacBio
11.17.1 PacBio Company Information
11.17.2 PacBio Cardiovascular Genetic Testing Product Offered
11.17.3 PacBio Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 PacBio Main Business Overview
11.17.5 PacBio Latest Developments
11.18 PerkinElmer Inc
11.18.1 PerkinElmer Inc Company Information
11.18.2 PerkinElmer Inc Cardiovascular Genetic Testing Product Offered
11.18.3 PerkinElmer Inc Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 PerkinElmer Inc Main Business Overview
11.18.5 PerkinElmer Inc Latest Developments
11.19 Qiagen
11.19.1 Qiagen Company Information
11.19.2 Qiagen Cardiovascular Genetic Testing Product Offered
11.19.3 Qiagen Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Qiagen Main Business Overview
11.19.5 Qiagen Latest Developments
11.20 Thermo Fisher Scientific, Inc
11.20.1 Thermo Fisher Scientific, Inc Company Information
11.20.2 Thermo Fisher Scientific, Inc Cardiovascular Genetic Testing Product Offered
11.20.3 Thermo Fisher Scientific, Inc Cardiovascular Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Thermo Fisher Scientific, Inc Main Business Overview
11.20.5 Thermo Fisher Scientific, Inc Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Cardiovascular Genetic Testing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Cytogenetic Testing
Table 3. Major Players of Biochemical Assays
Table 4. Major Players of Molecular Testing
Table 5. Cardiovascular Genetic Testing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Cardiovascular Genetic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Cardiovascular Genetic Testing Market Size Market Share by Type (2017-2022)
Table 8. Cardiovascular Genetic Testing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Cardiovascular Genetic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Cardiovascular Genetic Testing Market Size Market Share by Application (2017-2022)
Table 11. Global Cardiovascular Genetic Testing Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Cardiovascular Genetic Testing Revenue Market Share by Player (2020-2022)
Table 13. Cardiovascular Genetic Testing Key Players Head office and Products Offered
Table 14. Cardiovascular Genetic Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cardiovascular Genetic Testing Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Cardiovascular Genetic Testing Market Size Market Share by Regions (2017-2022)
Table 19. Americas Cardiovascular Genetic Testing Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Cardiovascular Genetic Testing Market Size Market Share by Country (2017-2022)
Table 21. Americas Cardiovascular Genetic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Cardiovascular Genetic Testing Market Size Market Share by Type (2017-2022)
Table 23. Americas Cardiovascular Genetic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Cardiovascular Genetic Testing Market Size Market Share by Application (2017-2022)
Table 25. APAC Cardiovascular Genetic Testing Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Cardiovascular Genetic Testing Market Size Market Share by Region (2017-2022)
Table 27. APAC Cardiovascular Genetic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Cardiovascular Genetic Testing Market Size Market Share by Type (2017-2022)
Table 29. APAC Cardiovascular Genetic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Cardiovascular Genetic Testing Market Size Market Share by Application (2017-2022)
Table 31. Europe Cardiovascular Genetic Testing Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Cardiovascular Genetic Testing Market Size Market Share by Country (2017-2022)
Table 33. Europe Cardiovascular Genetic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Cardiovascular Genetic Testing Market Size Market Share by Type (2017-2022)
Table 35. Europe Cardiovascular Genetic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Cardiovascular Genetic Testing Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Cardiovascular Genetic Testing Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Cardiovascular Genetic Testing Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Cardiovascular Genetic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Cardiovascular Genetic Testing Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Cardiovascular Genetic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Cardiovascular Genetic Testing Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Cardiovascular Genetic Testing
Table 44. Key Market Challenges & Risks of Cardiovascular Genetic Testing
Table 45. Key Industry Trends of Cardiovascular Genetic Testing
Table 46. Global Cardiovascular Genetic Testing Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Cardiovascular Genetic Testing Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Cardiovascular Genetic Testing Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Cardiovascular Genetic Testing Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Cardiovascular Genetic Testing Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Cardiovascular Genetic Testing Market Size Market Share Forecast by Application (2023-2028)
Table 52. Abbott Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 53. Abbott Cardiovascular Genetic Testing Product Offered
Table 54. Abbott Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Abbott Main Business
Table 56. Abbott Latest Developments
Table 57. Bio-Rad Laboratories Inc Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 58. Bio-Rad Laboratories Inc Cardiovascular Genetic Testing Product Offered
Table 59. Bio-Rad Laboratories Inc Main Business
Table 60. Bio-Rad Laboratories Inc Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Bio-Rad Laboratories Inc Latest Developments
Table 62. Danaher Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 63. Danaher Cardiovascular Genetic Testing Product Offered
Table 64. Danaher Main Business
Table 65. Danaher Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Danaher Latest Developments
Table 67. Daan Gene Co., Ltd Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 68. Daan Gene Co., Ltd Cardiovascular Genetic Testing Product Offered
Table 69. Daan Gene Co., Ltd Main Business
Table 70. Daan Gene Co., Ltd Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Daan Gene Co., Ltd Latest Developments
Table 72. F. Hoffmann-La Roche, Ltd Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 73. F. Hoffmann-La Roche, Ltd Cardiovascular Genetic Testing Product Offered
Table 74. F. Hoffmann-La Roche, Ltd Main Business
Table 75. F. Hoffmann-La Roche, Ltd Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. F. Hoffmann-La Roche, Ltd Latest Developments
Table 77. Genentech, Inc Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 78. Genentech, Inc Cardiovascular Genetic Testing Product Offered
Table 79. Genentech, Inc Main Business
Table 80. Genentech, Inc Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Genentech, Inc Latest Developments
Table 82. Genomictree, Inc Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 83. Genomictree, Inc Cardiovascular Genetic Testing Product Offered
Table 84. Genomictree, Inc Main Business
Table 85. Genomictree, Inc Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Genomictree, Inc Latest Developments
Table 87. HTG Molecular Diagnostics, Inc Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 88. HTG Molecular Diagnostics, Inc Cardiovascular Genetic Testing Product Offered
Table 89. HTG Molecular Diagnostics, Inc Main Business
Table 90. HTG Molecular Diagnostics, Inc Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. HTG Molecular Diagnostics, Inc Latest Developments
Table 92. Illumina, Inc Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 93. Illumina, Inc Cardiovascular Genetic Testing Product Offered
Table 94. Illumina, Inc Main Business
Table 95. Illumina, Inc Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Illumina, Inc Latest Developments
Table 97. Integragen Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 98. Integragen Cardiovascular Genetic Testing Product Offered
Table 99. Integragen Main Business
Table 100. Integragen Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Integragen Latest Developments
Table 102. Laboratory Corporation of America Holdings Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 103. Laboratory Corporation of America Holdings Cardiovascular Genetic Testing Product Offered
Table 104. Laboratory Corporation of America Holdings Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Laboratory Corporation of America Holdings Main Business
Table 106. Laboratory Corporation of America Holdings Latest Developments
Table 107. Luminex Corporation Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 108. Luminex Corporation Cardiovascular Genetic Testing Product Offered
Table 109. Luminex Corporation Main Business
Table 110. Luminex Corporation Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Luminex Corporation Latest Developments
Table 112. Molecular MD Corp Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 113. Molecular MD Corp Cardiovascular Genetic Testing Product Offered
Table 114. Molecular MD Corp Main Business
Table 115. Molecular MD Corp Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Molecular MD Corp Latest Developments
Table 117. Myriad Genetics, Inc Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 118. Myriad Genetics, Inc Cardiovascular Genetic Testing Product Offered
Table 119. Myriad Genetics, Inc Main Business
Table 120. Myriad Genetics, Inc Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Myriad Genetics, Inc Latest Developments
Table 122. Natera, Inc Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 123. Natera, Inc Cardiovascular Genetic Testing Product Offered
Table 124. Natera, Inc Main Business
Table 125. Natera, Inc Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. Natera, Inc Latest Developments
Table 127. Oxford Biodynamics Plc Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 128. Oxford Biodynamics Plc Cardiovascular Genetic Testing Product Offered
Table 129. Oxford Biodynamics Plc Main Business
Table 130. Oxford Biodynamics Plc Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 131. Oxford Biodynamics Plc Latest Developments
Table 132. PacBio Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 133. PacBio Cardiovascular Genetic Testing Product Offered
Table 134. PacBio Main Business
Table 135. PacBio Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 136. PacBio Latest Developments
Table 137. PerkinElmer Inc Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 138. PerkinElmer Inc Cardiovascular Genetic Testing Product Offered
Table 139. PerkinElmer Inc Main Business
Table 140. PerkinElmer Inc Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 141. PerkinElmer Inc Latest Developments
Table 142. Qiagen Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 143. Qiagen Cardiovascular Genetic Testing Product Offered
Table 144. Qiagen Main Business
Table 145. Qiagen Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 146. Qiagen Latest Developments
Table 147. Thermo Fisher Scientific, Inc Details, Company Type, Cardiovascular Genetic Testing Area Served and Its Competitors
Table 148. Thermo Fisher Scientific, Inc Cardiovascular Genetic Testing Product Offered
Table 149. Thermo Fisher Scientific, Inc Main Business
Table 150. Thermo Fisher Scientific, Inc Cardiovascular Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 151. Thermo Fisher Scientific, Inc Latest Developments
List of Figures
List of Figures
Figure 1. Cardiovascular Genetic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cardiovascular Genetic Testing Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Cardiovascular Genetic Testing Market Size Market Share by Type in 2021
Figure 7. Cardiovascular Genetic Testing in Alzheimer Disease
Figure 8. Global Cardiovascular Genetic Testing Market: Alzheimer Disease (2017-2022) & ($ Millions)
Figure 9. Cardiovascular Genetic Testing in Sickle Cell Anemia
Figure 10. Global Cardiovascular Genetic Testing Market: Sickle Cell Anemia (2017-2022) & ($ Millions)
Figure 11. Cardiovascular Genetic Testing in Cystic Fibrosis
Figure 12. Global Cardiovascular Genetic Testing Market: Cystic Fibrosis (2017-2022) & ($ Millions)
Figure 13. Cardiovascular Genetic Testing in Cancer
Figure 14. Global Cardiovascular Genetic Testing Market: Cancer (2017-2022) & ($ Millions)
Figure 15. Cardiovascular Genetic Testing in Other
Figure 16. Global Cardiovascular Genetic Testing Market: Other (2017-2022) & ($ Millions)
Figure 17. Global Cardiovascular Genetic Testing Market Size Market Share by Application in 2021
Figure 18. Global Cardiovascular Genetic Testing Revenue Market Share by Player in 2021
Figure 19. Global Cardiovascular Genetic Testing Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Cardiovascular Genetic Testing Market Size 2017-2022 ($ Millions)
Figure 21. APAC Cardiovascular Genetic Testing Market Size 2017-2022 ($ Millions)
Figure 22. Europe Cardiovascular Genetic Testing Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Cardiovascular Genetic Testing Market Size 2017-2022 ($ Millions)
Figure 24. Americas Cardiovascular Genetic Testing Value Market Share by Country in 2021
Figure 25. Americas Cardiovascular Genetic Testing Consumption Market Share by Type in 2021
Figure 26. Americas Cardiovascular Genetic Testing Market Size Market Share by Application in 2021
Figure 27. United States Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Cardiovascular Genetic Testing Market Size Market Share by Region in 2021
Figure 32. APAC Cardiovascular Genetic Testing Market Size Market Share by Application in 2021
Figure 33. China Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Cardiovascular Genetic Testing Market Size Market Share by Country in 2021
Figure 40. Europe Cardiovascular Genetic Testing Market Size Market Share by Type in 2021
Figure 41. Europe Cardiovascular Genetic Testing Market Size Market Share by Application in 2021
Figure 42. Germany Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Cardiovascular Genetic Testing Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Cardiovascular Genetic Testing Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Cardiovascular Genetic Testing Market Size Market Share by Application in 2021
Figure 50. Egypt Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Cardiovascular Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 56. APAC Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 57. Europe Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 59. United States Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 60. Canada Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 63. China Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 64. Japan Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 65. Korea Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 67. India Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 68. Australia Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 69. Germany Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 70. France Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 71. UK Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 72. Italy Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 73. Russia Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 74. Spain Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 77. Israel Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Cardiovascular Genetic Testing Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Medical Devices & Consumables Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets